Injection Of Chemical For Paralysis Of Nerve Muscles On Arm Or Leg, 1-4 Muscles, First Extremity in Connecticut
Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.
Top Providers in Connecticut
| Provider | Medicare | Services |
|---|---|---|
| Feingold, David MD | $125.71 | 154 |
| Raymond, Matthew D.O. | $123.97 | 130 |
| O'keefe, Joseph M.D. | $111.45 | 105 |
| Machado, Duarte M.D. | $114.91 | 77 |
| Hankenson, Jennifer M.D. | $125.80 | 47 |
| Habibi Khameneh, Behzad M.D. | $111.74 | 45 |
| Buckingham, Sarah MD | $127.17 | 33 |
| Demarcaida, Joy M.D. | $122.41 | 29 |
Connecticut Pricing in Context
In Connecticut, CPT code 64642 (Injection Of Chemical For Paralysis Of Nerve Muscles On Arm Or Leg, 1-4 Muscles, First Extremity) carries an average Medicare payment of $114.99 — 23% above the national benchmark of $93.73. 60 providers across the state submitted claims for this procedure in 2023, performing 1.0K total services. Individual payments in CT ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.
The average billed charge in Connecticut is $525.04, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Connecticut sits above the national Medicare average, commercial rates in the state may also run higher than the US median.
Using RAND 2024 commercial-to-Medicare ratios for Nervous System Surgery procedures, the estimated commercial insurance price in Connecticut lands near $380.17, with self-pay cash prices typically around $256.20. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.
Frequently Asked Questions
How much does Injection Of Chemical For Paralysis Of Nerve Muscles On Arm Or Leg, 1-4 Muscles, First Extremity cost in Connecticut?
The average Medicare payment for Injection Of Chemical For Paralysis Of Nerve Muscles On Arm Or Leg, 1-4 Muscles, First Extremity in Connecticut is $114.99, which is 23% above the national average of $93.73. Providers in CT typically bill $525.04 for this procedure.
What does Injection Of Chemical For Paralysis Of Nerve Muscles On Arm Or Leg, 1-4 Muscles, First Extremity cost with insurance in Connecticut?
With commercial insurance in Connecticut, Injection Of Chemical For Paralysis Of Nerve Muscles On Arm Or Leg, 1-4 Muscles, First Extremity costs an estimated $380.17. Without insurance, the estimated cash price is $256.20. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.
How many providers perform Injection Of Chemical For Paralysis Of Nerve Muscles On Arm Or Leg, 1-4 Muscles, First Extremity in Connecticut?
60 providers in Connecticut billed Medicare for Injection Of Chemical For Paralysis Of Nerve Muscles On Arm Or Leg, 1-4 Muscles, First Extremity in 2023, performing 1.0K total services. Medicare payments ranged from N/A to N/A depending on the provider.
Is Injection Of Chemical For Paralysis Of Nerve Muscles On Arm Or Leg, 1-4 Muscles, First Extremity cheaper in Connecticut than the national average?
No — Injection Of Chemical For Paralysis Of Nerve Muscles On Arm Or Leg, 1-4 Muscles, First Extremity costs 23% above the national average in Connecticut. The state average Medicare payment is $114.99 compared to $93.73 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.
Related Guides
Related Data Sources
Data from CMS Medicare Physician & Other Practitioners (2023).
Read our methodology — how this data is sourced, computed, and verified.